Trials / Conditions / Foetal Growth Problem

Foetal Growth Problem

13 registered clinical trials studyying Foetal Growth Problem.

Status	Trial	Sponsor	Phase
Completed	Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated NCT01327924	Novo Nordisk A/S	—
Completed	Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents NCT01245374	Novo Nordisk A/S	Phase 4
Completed	Observational Study of the Safety and Efficacy of Norditropin® in Patients With SGA (Small for Gestational Age NCT01110928	Novo Nordisk A/S	—
Completed	Long Term Metabolic Safety of Norditropin® Treatment of Small for Gestational Age (SGA) Subjects NCT00787878	Novo Nordisk A/S	—
Completed	Observational Prospective Study on Patients Treated With Norditropin® NCT00960128	Novo Nordisk A/S	—
Completed	Growth Hormone Treatment in Children Born Small for Gestational Age: Assessment of Satisfaction NCT00519844	Novo Nordisk A/S	Phase 4
Completed	Growth Hormone Treatment in Children Born Small for Gestational Age (SGA) NCT00184717	Novo Nordisk A/S	Phase 3
Completed	Efficacy and Safety of Growth Hormone Treatment in Children Small for Gestational Age NCT00557336	Novo Nordisk A/S	Phase 3
Completed	Efficacy on Height in SGA Children Treated With Growth Hormone NCT00184756	Novo Nordisk A/S	Phase 3
Completed	Safety and Efficacy of Long-term Somatropin Treatment in Children NCT01543867	Novo Nordisk A/S	—
Completed	Long Term Effect of Somatropin in Subjects With Intrauterine Growth Retardation NCT01734447	Novo Nordisk A/S	Phase 4
Completed	Growth Hormone Treatment of Children Born With Retarded Intrauterine Growth at Age 2-5 Years NCT00184691	Novo Nordisk A/S	Phase 3
Completed	Growth Hormone Treatment of Children Diagnosed of Intrauterine Growth Retardation NCT01697644	Novo Nordisk A/S	Phase 4